PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
3.31%
Growth of 3.31% versus flat Healthcare revenue. Walter Schloss would verify growth quality.
3.41%
Cost growth of 3.41% versus flat Healthcare costs. Walter Schloss would verify cost control.
2.91%
Growth of 2.91% versus flat Healthcare gross profit. Walter Schloss would verify quality.
-0.39%
Margin decline while Healthcare median is 0.00%. Seth Klarman would investigate competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.89%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
1.88%
Operating expenses growth 50-90% of Healthcare median of 2.65%. Mohnish Pabrai would examine discipline.
3.15%
Total costs growth 1.1-1.25x Healthcare median of 2.54%. John Neff would investigate control.
-7.14%
Interest expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
6.12%
D&A growth exceeding 1.5x Healthcare median of 0.90%. Jim Chanos would check for overinvestment.
5.05%
EBITDA growth while Healthcare declines. Peter Lynch would examine advantages.
1.68%
Margin change of 1.68% versus flat Healthcare. Walter Schloss would verify quality.
7.71%
Operating income growth while Healthcare declines. Peter Lynch would examine advantages.
4.25%
Margin change of 4.25% versus flat Healthcare. Walter Schloss would verify quality.
-15.70%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
4.55%
Pre-tax income growth while Healthcare declines. Peter Lynch would examine advantages.
1.20%
Margin change of 1.20% versus flat Healthcare. Walter Schloss would verify quality.
5.41%
Tax expense change of 5.41% versus flat Healthcare. Walter Schloss would verify strategy.
4.16%
Net income growth while Healthcare declines. Peter Lynch would examine advantages.
0.82%
Margin change of 0.82% versus flat Healthcare. Walter Schloss would verify quality.
4.15%
EPS change of 4.15% versus flat Healthcare. Walter Schloss would verify quality.
4.15%
Diluted EPS change of 4.15% versus flat Healthcare. Walter Schloss would verify quality.
-0.00%
Share count reduction while Healthcare median is 0.20%. Seth Klarman would investigate strategy.
-0.00%
Diluted share reduction while Healthcare median is 0.19%. Seth Klarman would investigate strategy.